Clinical Research Network India: A Nationwide Consortium of Experienced Investigators & Clinical Researcher
Dr. Anit Singh, Founder & CEO
Dr. Anupriya Khare Roy, Director - Science & Communication, Nidhi Singh Rai, Director - Clinical Operation
The overwhelming market growth is triggering demand for CROs, propelling them to expand their service coverage, as the biopharmaceutical and medical device companies are constantly in pursuit of a single CRO-partner to avail end-to-end services. The Clinical Research Network India (CRN India) has become the most convenient destinations to such organizations by comprising a nationwide consortium of experienced investigators & clinical research sites that aims to provide a comprehensive solution for executing high quality, ethical clinical research & studies – from end-to-end.
CRN India’s network partners with every stakeholder of the industry, including researchers & clinicians, board & GCP certified practicing primary care physicians (across diverse core therapeutic areas), other CROs, site management organizations, the government, healthcare associations, non-profit organizations, biopharmaceutical & medical device companies, and most importantly, the patients and the public. In other words, while being a CRO for phase I-to-IV studies, CRN India with over 100 clinical trial sites in 29 states is building an ecosystem in the industry with a robust infrastructure to facilitate and accelerate the development of life-saving drugs & devices that save lives and improve the quality of life.
A One-Stop-Shop Solution
The challenges tethered to the clinical trial industry are multifarious in nature. While the complexity of trials itself is the single largest challenge, other hurdles include everything from selecting the right investigator to recruiting the right patients, meticulous regulatory requirements (& getting approvals), and high cost. Millions of potentially beneficial product & healthcare devices get stuck on these stumbling blocks every year and never reach the public. CRN India offers a one-stop-shop solution to all these challenges, allowing worthy products & devices to be clinically tested and finally reach the market. “We help the sponsors choose investigators and research sites that are best suited for their budget, requirements, quality needs and interest from our wide database. Our team also helps in identifying & recruiting patients for portfolio studies and keeping the database during trial, which makes the researchers confident of completing the clinical trials on time with quality – on everything from drugs to biologicals, vaccines, and devices in both adult & pediatric population,” asserts Dr. Anit Singh (MBBS, MD from AIIMS), Founder & CEO, Clinical Research Network India, who is a scientific entrepreneur with exceptional medicinal acumen, spirit & passion to discover, and above all, a commitment to serve the people.
CRN India further closes the gaps by extending its services to facilitate clinical study approval (including ethics committee and institutional review board approval) assistance, science writer for protocol development (including background research and data analysis), and at large and most importantly, a fast, secure & ethical conduct of the study, ensuring the sanctity of the clients’ intellectual properties. “We navigate clients through potential regulatory hurdles
to ensure the highest quality of regulatory dossier submission and compliance with regional & local requirements. Furthermore, our group of professionals also aids in product development management, promising successful approval,” adjoins Dr. Anit. The clients indeed can avail CRN India’s end-to-end trial management services on a standalone or package-of-services model.
On an International Mission
Dr. Anit established CRN India in 2015, taking a long stride in the direction of his mission to provide the highest levels of excellence, & quality and ethical clinical research services imbued with passion, knowledge and integrity. He in fact foresaw the need for a consortium of experienced clinicians & expert researchers in conducting high level research and in turn accelerating the development of healthcare products & devices. After almost five years from its inception, the company today has come a long way, remaining strictly inclined to its vision and having the experience of conducting multiple clinical trials for dozens of sponsors and involving in promoting those products & devices in the market. CRN India conducts every clinical trial in compliance with ICH-GCP (Good Clinical Practice as defined by the International Conferences on Harmonization (ICH)) and Schedule Y guidelines with all the necessary approvals from the ethics committee & the institutional review board (EC/IRB).
A Bright Future
“Going forward, in the next five years, we foresee a significant upsurge in the healthcare market. This will be driven by the advent of multiple startups and small & medium enterprises that have an interest in diverse areas of healthcare, including but not limited to pharmaceutical drug development & drug delivery systems, medical devices, and complementary or alternative medicines such as Ayurveda & herbal medicines,” adjoins
Dr. Anit. Needless to say, developing new technologies and engendering inventions that could shape into revolutionary drugs and medical devices requires conducting continuous ethical clinical trials & assessments. Given the huge size of the ecosystem it has created, it’s a high bet that CRN India will flourish exponentially over these market opportunities.
The Research And Markets predicts a $3.15 billion future for Indian clinical trials industry by 2025; not to mention the flaring international market. CRN India’s vision to provide economical CRO services – to national & international pharma, biotech, medical device, diagnostic, food-nutraceutical, and cosmetic industries – is tailor-made to seize this opportunity..
Key Management:
Dr. Anit Singh, Founder & CEO
An MBBS & MD (AIIMS), Dr. Anit is a scientific entrepreneur with exceptional medicinal acumen, spirit and a passion to discover, and above all, a commitment to serve the people. He brings on board his vast and varied experiences in successfully completing global clinical trials for pharmaceutical giants like Biogen Idec, Merck, Janssen J&J, Victhom Human Bionics, Wyeth, Mylan, Bharat Biotech and Panacea Biotech, among others. He has participated in more than 200 trials across the world and has more than 50 publications & abstracts to his candidature.
“We guide clients through potential regulatory hurdles to ensure the highest quality of regulatory dossier submission and compliance with regional & local requirements”
Dr. Anupriya Khare Roy, Director – Science & Communication
Dr. Anupriya holds a Med. Biotech from AIIMS, PhD from NII, and Fellowship from Stanford University. She is a scientific researcher with more than 20 years of experience in field of Life Sciences. Trained as an Immunologist, she has extensive knowledge of immune system functioning and advanced cutting-edge biomedical techniques that are employed in current medical research. In addition, her experience in translational clinical research ranges from designing animal models to conducting human patient studies.
Nidhi Singh Rai, Director – Clinical Operation
A B. Pharm, Nidhi serves as the Country Head of Clinical Operations CRN India. Over the years, she has established herself to meet the ever-growing performance and quality expectations at the level of clinical trial sites. She understands the hidden pitfalls of clinical trial process for the execution of studies in a flawless and time-bound manner.
Offices: New Delhi (Headquarter), & Hyderabad
Offerings:
• Clinical Trial Management
• Clinical Data Management & Biostatistical Services
• Research Site Identification
• Clinical Study Approval (including EC/IRB approval),
• Science Writing: Protocol Development (study feasibility, background research, writing study protocols and reports, data analysis, and much more)
• Regulatory submissions
On an International Mission
Dr. Anit established CRN India in 2015, taking a long stride in the direction of his mission to provide the highest levels of excellence, & quality and ethical clinical research services imbued with passion, knowledge and integrity. He in fact foresaw the need for a consortium of experienced clinicians & expert researchers in conducting high level research and in turn accelerating the development of healthcare products & devices. After almost five years from its inception, the company today has come a long way, remaining strictly inclined to its vision and having the experience of conducting multiple clinical trials for dozens of sponsors and involving in promoting those products & devices in the market. CRN India conducts every clinical trial in compliance with ICH-GCP (Good Clinical Practice as defined by the International Conferences on Harmonization (ICH)) and Schedule Y guidelines with all the necessary approvals from the ethics committee & the institutional review board (EC/IRB).
Our team also helps in identifying & recruiting patients for portfolio studies and keeping the database during trial, which makes the researchers confident of completing the clinical trials on time with quality
A Bright Future
“Going forward, in the next five years, we foresee a significant upsurge in the healthcare market. This will be driven by the advent of multiple startups and small & medium enterprises that have an interest in diverse areas of healthcare, including but not limited to pharmaceutical drug development & drug delivery systems, medical devices, and complementary or alternative medicines such as Ayurveda & herbal medicines,” adjoins
Dr. Anit. Needless to say, developing new technologies and engendering inventions that could shape into revolutionary drugs and medical devices requires conducting continuous ethical clinical trials & assessments. Given the huge size of the ecosystem it has created, it’s a high bet that CRN India will flourish exponentially over these market opportunities.
The Research And Markets predicts a $3.15 billion future for Indian clinical trials industry by 2025; not to mention the flaring international market. CRN India’s vision to provide economical CRO services – to national & international pharma, biotech, medical device, diagnostic, food-nutraceutical, and cosmetic industries – is tailor-made to seize this opportunity..
Key Management:
Dr. Anit Singh, Founder & CEO
An MBBS & MD (AIIMS), Dr. Anit is a scientific entrepreneur with exceptional medicinal acumen, spirit and a passion to discover, and above all, a commitment to serve the people. He brings on board his vast and varied experiences in successfully completing global clinical trials for pharmaceutical giants like Biogen Idec, Merck, Janssen J&J, Victhom Human Bionics, Wyeth, Mylan, Bharat Biotech and Panacea Biotech, among others. He has participated in more than 200 trials across the world and has more than 50 publications & abstracts to his candidature.
“We guide clients through potential regulatory hurdles to ensure the highest quality of regulatory dossier submission and compliance with regional & local requirements”
Dr. Anupriya Khare Roy, Director – Science & Communication
Dr. Anupriya holds a Med. Biotech from AIIMS, PhD from NII, and Fellowship from Stanford University. She is a scientific researcher with more than 20 years of experience in field of Life Sciences. Trained as an Immunologist, she has extensive knowledge of immune system functioning and advanced cutting-edge biomedical techniques that are employed in current medical research. In addition, her experience in translational clinical research ranges from designing animal models to conducting human patient studies.
Nidhi Singh Rai, Director – Clinical Operation
A B. Pharm, Nidhi serves as the Country Head of Clinical Operations CRN India. Over the years, she has established herself to meet the ever-growing performance and quality expectations at the level of clinical trial sites. She understands the hidden pitfalls of clinical trial process for the execution of studies in a flawless and time-bound manner.
Offices: New Delhi (Headquarter), & Hyderabad
Offerings:
• Clinical Trial Management
• Clinical Data Management & Biostatistical Services
• Research Site Identification
• Clinical Study Approval (including EC/IRB approval),
• Science Writing: Protocol Development (study feasibility, background research, writing study protocols and reports, data analysis, and much more)
• Regulatory submissions
